Authors:
WANDT H
FRANK M
EHNINGER G
SCHNEIDER C
BRACK N
DAOUD A
FACKLERSCHWALBE I
FISCHER J
GACKLE R
GEER T
HARMS P
LOFFLER B
OHL S
OTREMBA B
RAAB M
SCHONROCKNABULSI P
STROBEL G
WINTER R
LINK H
Citation: H. Wandt et al., SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/, Blood, 91(10), 1998, pp. 3601-3606
Authors:
LINK H
WANDT H
SCHONROCKNABULSI P
EHNINGER G
FRANKE A
GACKLE R
GEER T
STROBEL G
LINKESCH W
KRIEGER O
NIEDERWIESER D
NIKIFORAKIS E
OHL S
OTREMBA B
PITTERMANN E
SCHMIDT H
TISCHLER J
WEISS J
WILHELM M
BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35
Authors:
HUBNER G
LINK H
SCHONROCKNABULSI P
WANDT H
GRAMATZKI M
LOFFLER B
FACKLERSCHWALBE I
QUEISSER W
BRACK N
GEER T
RAAB M
OHL S
SCHNEIDER B
SCHNEIDER C
FREUND M
POLIWODA H
EHNINGER G
Citation: G. Hubner et al., INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL, Medizinische Klinik, 91, 1996, pp. 26-32
Authors:
LINK H
WANDT H
SCHONROCKNABULSI P
EHNINGER G
FRANKE A
GACKLE R
GEER T
STROBEL G
LINKESCH W
KRIEGER O
NIEDERWIESER D
NIKIFORAKIS E
OHL S
OTREMBA B
PITTERMANN E
SCHMIDT H
TISCHLER J
WEISS J
WILHELM M
BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654
Authors:
LINK H
EHNINGER G",SCHONROCKNABULSI,GRAMATZKI,"FRANKE A
EINSELE H
TISCHLER J
BRACK N
OTREMBA B
LUTZ M
GACKLE R
OHL S
HEIDEMANN E
WILHELM M
LOFFLER B
WEISS J
GEER T
DIEHL S
WANDT H
Citation: H. Link et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 2723-2723